Heart Metabolics has launched in Ireland with $20m in series-A funding from a group of investors led by Seroba Kernel Life Sciences and US firm venBio.
DVI Equity Partners, Frontline Ventures and Enterprise Ireland also take part
Newcomer Target Global and existing investor Round Hill Ventures also take part in the round
GP invests €7.3m in the France-based point-of-sale merchandising equipment provider
Azimut appoints Jeffry Brown as CEO of AACP; Brown previously worked at Dyal Capital Partners